Skip to main content

Invenire Partners, LP

Location
RIDGEFIELD, CT
Portfolio Value
Micro $55,696,149
Diversification
Diversified
Filing Date
Global Rank
#5,038 / 6,689 ▼ 44 · as of Sep 2022
Top Industry
Medical Devices 20.4%
3Y Alpha vs SPY
-14.6%
Period ended 3 years ago
Filed Nov 14, 2022 · 3y
4 quarters · since Dec 2021

Clone Performance

Jun 2023–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+20.2%
SPY
+76.8%
Annualised alpha
-14.6%
Max drawdown
−34.0%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

19 positions · as of Sep 30, 2022 · Δ vs Jun 30, 2022
Top Position
9.8%
+2.4 pts
Top 5
40.3%
+8.0 pts
Top 10
66.9%
+6.6 pts
HHI
603
Dec 2021 → Sep 2022 · range 536 – 605
Diversified+67

Portfolio Trend

4 quarters · across all stocks

Sector Breakdown

As of Sep 30, 2022
Sector % Portfolio Value
Healthcare 40.8% $22,705,953
Technology 24.2% $13,494,075
Industrials 20.4% $11,341,362
Communication Services 10.8% $6,038,757
Consumer Cyclical 3.8% $2,116,002

Last Quarter's Activity

Export CSV
Sep 30, 2022 vs Jun 30, 2022

Added To

Positions the filer increased
8 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
3 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
4 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
6 positions
Ticker Shares Value Open

Portfolio Positions

Export CSV View 13F filing
19 positions · $55,696,149 total · as of Sep 30, 2022
Ticker Company Shares Value (USD) % of Portfolio History